Innovations in Food Allergy Treatment: What Healthcare Providers Need to Know

R. Sharon Chinthrajah, M.D. is an Associate Professor and the Co-Director of the Sean N Parker Center for Allergy and Asthma Research. Dr. Chinthrajah received her MD from Drexel University College of Medicine, completed her Internal Medicine training and a chief residency at California Pacific Medical Center, and sub-specialized in Pulmonary/Critical Care and Allergy/Immunology at Boston Medical Center. Her research is focused on developing novel therapeutic options for allergic diseases as well as unraveling the molecular mechanisms driving therapeutic response. She has extensive experience in performing both academic and industry-sponsored clinical trials investigating allergic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis, asthma, and COVID-19. Her research has led to the publication of over 160 research articles in peer-reviewed journals, including studies that led to the FDA approval of omalizumab for the treatment of food allergy. She is dedicated to training the next generation of clinical researchers and continues to act as a mentor for students and junior faculty interested in pursuing medical research.